Making Sense of Opioid Litigation

In Oct 2019, three major drug distributors and a drug manufacturer reached a $260 million settlement with two Ohio counties to avoid the first federal opioid trial, which was to be a test case for thousands of lawsuits filed against drug manufacturers, distributors, and retailers over their role in the opioid crisis. What does this mean for future opioid litigation, and what impact will these lawsuits have on the opioid crisis? What public health lessons can be applied from tobacco litigation in the 1990s?